HemaSphere (Jun 2022)

S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS.

  • H. Garelius,
  • A. Smith,
  • T. Bagguley,
  • A. Taylor,
  • P. Fenaux,
  • D. Bowen,
  • A. Symeonidis,
  • M. Mittelmann,
  • R. Stauder,
  • J. Čermák,
  • G. Sanz,
  • S. Langemeijer,
  • L. Malcovati,
  • U. Germing,
  • R. Itzykson,
  • A. Guerci-Bresler,
  • D. Culligan,
  • I. Kotsianidis,
  • K. Koinig Mag,
  • C. van Marrewijk,
  • S. Crouch,
  • T. de Witte,
  • E. Hellström-Lindberg

DOI
https://doi.org/10.1097/01.HS9.0000843564.40783.b4
Journal volume & issue
Vol. 6
pp. 69 – 70

Abstract

Read online

No abstracts available.